Targeted photothermal ablation of melanoma

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201000052C
Awardee
Awarding agency
Obligated
$200,000

Award facts

Contract value 100% obligated
$200,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 18 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Houston, TX 77054, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $200,000

About this award

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanospectra Biosciences, Inc. for "Targeted Photothermal Ablation of Melanoma". The contract has a firm fixed price ceiling of $200,000.00 and a period of performance ending on September 23, 2011. As an SBIR Phase I award, this contract is focused on feasibility research and development of the proposed technology.

Quick answers

Who was awarded contract HHSN261201000052C?

HHSN261201000052C was awarded to Nanospectra Biosciences, Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2010.

How much is contract HHSN261201000052C worth?

The government has obligated $200,000 on HHSN261201000052C.

Was contract HHSN261201000052C competed?

The extent of competition for HHSN261201000052C was full and open competition after exclusion of sources. The government received 18 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award